A Cancer Conundrum: Too Many Drug Trials, Too Few Patients
Saturday, August 12, 2017 - 13:42
in Health & Medicine
Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients.